Location History:
- New York, NY (US) (2002)
- Matawan, NJ (US) (2007 - 2010)
Company Filing History:
Years Active: 2002-2010
Title: The Innovative Contributions of Richard Beresis
Introduction
Richard Beresis, an accomplished inventor based in Matawan, NJ, has made significant advancements in the field of pharmaceutical sciences. With a total of four patents to his name, Beresis is recognized for his innovative work in developing selective modulators for glucocorticoid receptors, which are integral in treating various autoimmune and inflammatory conditions.
Latest Patents
Beresis's latest patents demonstrate his expertise in creating novel therapeutic compounds. His first patent focuses on **Selective Spirocyclic Glucocorticoid Receptor Modulators**, which include compounds of Formula (I) and Formula (II) or their pharmaceutically acceptable salts or hydrates. These compounds have shown potential as selective glucocorticoid receptor ligands for addressing a range of autoimmune and inflammatory diseases.
The second significant patent from Beresis is for **Selective Non-Steroidal Glucocorticoid Receptor Modulators**. This invention encompasses compounds of Formula (I) or their acceptable salts or hydrates, offering innovative solutions as non-steroidal selective glucocorticoid receptor modulators. These modulators are designed to provide therapeutic benefits while minimizing undesirable side effects, toxicity, and metabolism concerns that are often associated with steroidal ligands.
Career Highlights
Throughout his career, Richard Beresis has been associated with renowned pharmaceutical companies such as Merck & Company, Inc. and Merck Sharp & Dohme Corporation. His contributions to drug development and research have positioned him as a key player in his field, particularly in the advancement of glucocorticoid therapy.
Collaborations
In his journey as an inventor, Beresis has collaborated with notable professionals in the industry, including Steven L. Colletti and Amjad Ali. These collaborations have facilitated innovative research and the sharing of ideas, further enhancing the impact of his work in developing effective treatments for autoimmune and inflammatory diseases.
Conclusion
Richard Beresis exemplifies the spirit of innovation within the pharmaceutical realm. His contributions through various patented inventions are not only a testament to his creativity but also to his commitment to improving healthcare solutions. As the field continues to evolve, Beresis's work will undoubtedly play a critical role in shaping future therapeutic strategies.